Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 24Gastrointestinal 11Head & Neck 8Lymphoid 3Breast 3Sarcoma 2Gynecologic 2Dermatologic 2CNS 2

Conditions

Neuroblastoma 1Brain Neoplasms 1

Interventions

Temozolomide 66Radiotherapy 52Carboplatin 25Bevacizumab 21Cisplatin 19Radiosurgery 18Vincristine 17Etoposide 17Cyclophosphamide 17Surgical Procedures, Operative 13Magnetic Resonance Spectroscopy 13Chemotherapy, Adjuvant 11Melphalan 10Lomustine 10Drug Therapy 10Filgrastim 9Erlotinib Hydrochloride 9apatinib 8Pemetrexed 83-Iodobenzylguanidine 8anlotinib 7Radiation 7Peripheral Blood Stem Cell Transplantation 7Methotrexate 7Thiotepa 6Isotretinoin 6Irinotecan 6Ifosfamide 6Doxorubicin 6Carmustine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × endostar protein × CNS × Clear all
NCT02615106 2016-06-14

Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Unknown
60 enrolled
CNS

Neuroblastoma

NCT01410370 2013-04-24

Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 2 Unknown
80 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡